A five - day course of the common antibiotic moxifloxacin was given to 28 people, half of whom also took DAV132 twice a day throughout the treatment, and for two extra days at the end. (newscientist.com)
According to the CEU UCH research team, «the ocular release of moxifloxacin with this insert would make for an improved treatment of some ocular illnesses such as bacterial endophthalmitis, an infection of the eyeball which can appear after suffering a wound or as a complication following intraocular surgery. (sciencedaily.com)
The development of this ocular insert to administer moxifloxacin opens new treatment possibilities for ocular infections. (sciencedaily.com)